URBANI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 1.061
EU - Europa 439
AS - Asia 236
AF - Africa 42
SA - Sud America 1
Totale 1.779
Nazione #
US - Stati Uniti d'America 1.049
SE - Svezia 199
IT - Italia 135
CN - Cina 124
SG - Singapore 70
BG - Bulgaria 35
DE - Germania 31
CI - Costa d'Avorio 24
VN - Vietnam 23
SN - Senegal 15
CA - Canada 12
FI - Finlandia 12
GB - Regno Unito 11
TR - Turchia 7
FR - Francia 5
IN - India 5
RU - Federazione Russa 5
HK - Hong Kong 3
CZ - Repubblica Ceca 2
BE - Belgio 1
BJ - Benin 1
CL - Cile 1
DZ - Algeria 1
IE - Irlanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
PH - Filippine 1
PT - Portogallo 1
UA - Ucraina 1
Totale 1.779
Città #
Woodbridge 184
Fairfield 117
Houston 98
Chandler 78
Santa Clara 76
Ann Arbor 64
Ashburn 59
Seattle 59
Shanghai 47
Wilmington 38
Cambridge 36
Sofia 35
Beijing 34
New York 33
Florence 32
Milan 31
Singapore 29
Abidjan 24
Boardman 21
Bremen 16
Princeton 16
Dakar 15
Lawrence 15
Pisa 15
Medford 14
Des Moines 11
Ottawa 11
Frankfurt am Main 10
Serra 10
Lancaster 7
Nanjing 7
Zhengzhou 7
Changsha 6
Istanbul 6
Dong Ket 5
Falls Church 5
Quanzhou 5
Xiamen 5
Helsinki 4
Marseille 4
Pune 4
Redwood City 4
Venturina 4
Dearborn 3
Hong Kong 3
Los Angeles 3
San Diego 3
Auburn Hills 2
Brescia 2
Council Bluffs 2
Genoa 2
Grafing 2
Kent 2
Lucca 2
Ogden 2
Phoenix 2
Prague 2
Redmond 2
Rome 2
Sovicille 2
Vicopisano 2
Albissola Marina 1
Almaty 1
Bari 1
Bishkek 1
Brussels 1
Capannori 1
Cotonou 1
Düsseldorf 1
Fuzhou 1
Hefei 1
Izmir 1
Jiaxing 1
Jinan 1
Kunming 1
London 1
Lusciano 1
Marche 1
Mila 1
Munich 1
Naples 1
Norwalk 1
Rabat 1
Shenyang 1
Shenzhen 1
Simi Valley 1
Southampton 1
Toronto 1
Wuhan 1
Totale 1.369
Nome #
Growth Hormone Is Necessary for the p53-Mediated, Obesity-Induced Insulin Resistance in Male C57BL/6J × CBA Mice 155
Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study 137
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 136
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 130
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 130
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 121
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 118
The beneficial effect of acromegaly control on blood pressure values in normotensive patients 112
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients 109
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 104
null 94
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy. 91
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 74
PCB153 reduces apoptosis in primary cultures of murine pituitary cells through the activation of NF-κB mediated by PI3K/Akt. 67
null 57
DISEASE ACTIVITY AND LIFESTYLE INFLUENCE COMORBIDITIES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH ACROMEGALY 54
Divergent effects of dioxin- or non- dioxin- Like polychlorinated biphenyls on the apoptosis of primary cell culture from the mouse dioxin pituitary gland 43
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 31
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 26
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 24
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 13
Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up 3
Totale 1.829
Categoria #
all - tutte 5.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 0 0 0 0 0 33 29 32 29 21 8
2020/2021117 7 7 11 1 6 3 11 9 14 10 7 31
2021/2022253 3 5 3 33 51 28 6 10 20 8 32 54
2022/2023334 57 47 24 23 21 32 1 31 65 1 28 4
2023/2024187 6 17 31 15 21 48 10 8 2 2 10 17
2024/2025250 7 20 4 42 56 102 19 0 0 0 0 0
Totale 1.829